Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

1.4K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.4K
Drug Therapy01:28

Drug Therapy

361
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
361
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

1.5K
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
1.5K
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

320
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
320
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

109
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
109
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

247
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
247

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The association between interhospital transfer and sepsis guideline adherence among rural emergency department patients.

PloS one·2026
Same author

Focused Ultrasound Neuromodulation for Substance Use Disorder.

Biological psychiatry·2026
Same author

Emergency Medicine Funding Within NIH Is the Least Concentrated of Any Specialty.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine·2026
Same author

Evaluating Clinicians' Perspectives on Initiation of Medications for Opioid Use Disorder During Psychiatric Admissions.

Journal of addiction medicine·2026
Same author

Comparison of Single-Dose Intravenous Insulin Regular vs. Insulin Lispro for Hyperkalemia Treatment in the Emergency Department: The SIR-LISPRO Trial.

The American journal of emergency medicine·2026
Same author

Permissive Telehealth State Licensure Policies Are Associated with Increased Telehealth Utilization.

Telemedicine journal and e-health : the official journal of the American Telemedicine Association·2025

Related Experiment Video

Updated: Mar 11, 2026

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.7K

Pharmacotherapy for Alcohol Use Disorders: Physicians' Perceptions and Practices.

Caridad Ponce Martinez1, Priyanka Vakkalanka2, Nassima Ait-Daoud3

  • 1Department of Psychiatry, Yale School of Medicine , New Haven, CT , USA.

Frontiers in Psychiatry
|November 30, 2016
PubMed
Summary

Most physicians use medications for alcohol use disorders (AUDs). Increased training on pharmacotherapy can improve treatment, addressing efficacy concerns and promoting individualized patient care for better outcomes.

Keywords:
alcohol use disorderfamily physicianspharmacotherapypsychiatristssurvey

More Related Videos

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.7K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.9K

Related Experiment Videos

Last Updated: Mar 11, 2026

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice
07:31

Murine Drinking Models in the Development of Pharmacotherapies for Alcoholism: Drinking in the Dark and Two-bottle Choice

Published on: January 7, 2019

8.7K
Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder
05:12

Chronic Intermittent Ethanol Vapor Exposure Paired with Two-Bottle Choice to Model Alcohol Use Disorder

Published on: June 23, 2023

1.7K
Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
09:29

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods

Published on: August 4, 2022

2.9K

Area of Science:

  • Addiction Medicine
  • Psychiatry
  • Family Medicine

Background:

  • Alcohol use disorders (AUDs) are a significant cause of illness and death.
  • Current treatment guidelines recommend pharmacotherapy, yet counseling remains the primary intervention.
  • Physician practices and barriers to medication use for AUDs require investigation.

Purpose of the Study:

  • To survey psychiatrists and family medicine (FM) physicians on their treatment practices for AUDs.
  • To identify barriers hindering the use of pharmacotherapy for AUDs.
  • To develop strategies for increasing physician knowledge and utilization of AUD medications.

Main Methods:

  • An anonymous online survey was distributed nationwide to psychiatrists and FM physicians.
  • The survey collected demographic data and assessed the prescription of FDA-approved and off-label medications for AUDs.
  • Factors influencing increased pharmacotherapy for AUDs were examined.

Main Results:

  • Out of 475 respondents, 74.7% reported using medications for AUDs.
  • Psychiatrists were more likely than FM physicians to prescribe specific AUD medications.
  • FM physicians expressed more concerns regarding medication efficacy.

Conclusions:

  • Most surveyed physicians utilize medications for AUDs, though efficacy concerns persist.
  • Enhanced education on pharmacotherapy and predictors of treatment response is needed.
  • Improved understanding can lead to more individualized and effective AUD treatment approaches.